Effect of glucagon-like peptide-1 on β- and α-cell function in isolated islet and whole pancreas transplant recipients

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 1, 2009, Pages 181-189

  Rickels, Michael R ^a   Mueller, Rebecca ^a   Markmann, James F ^a,b   Naji, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PLACEBO;

ADULT; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL SECRETION; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; DEPLETION; FEMALE; GLUCOSE INFUSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; INFUSION RATE; INNER CELL MASS; INSULIN RELEASE; MALE; PANCREAS; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; SECRETORY GRANULE;

EID: 58149375854     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1806     Document Type: Article

References (33)

1. Frank A, Deng SP, Huang XL, Velidedeoglu E, Bae YS, Liu CY, Stephenson R, Mohiuddin M, Thambipillai T, Markmann E, Palanjian M, Sellers M, Naji A, Barker CF, Markmann JF 2004 Transplantation for type 1 diabetes. Comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg 240:631-640
2. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL 2005 β-Cell function following human islet transplantation for type 1 diabetes. Diabetes 54:100-106
3. Eich T, Eriksson O, Lundgren T 2007 Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 356:2754-2755
4. Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G, Ysebaert D, Roep B, Vandemeulebroucke E, Marichal M, 't Veld PI, Bogdani M, Hendrieckx C, Gorus F, Ling ZD, van Rood J, Pipeleers D 2006 Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 103:17444-17449
5. D'Alessio DA, Vahl TP 2004 Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. Am J Physiol 286:E882-E890
6. Farilla L, Bulotta A, Hirshberg B, Calzi SL, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R 2003 Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149-5158
7. Ginier P, Levin SR, Swafford G, Soon-Shiong P 1988 Absence of the "incretin" phenomenon in the autotransplanted human pancreas. Pancreas 3:740-741
8. vander Burg MPM, van Suylichem PTR, Guicherit OR, Frolich M, Lemkes HHPJ, Gooszen HG 1997 Glucoregulation after canine islet transplantation: contribution of insulin secretory capacity, insulin action, and the entero-insular axis. Cell Transplantation 6:497-503
9. Fung M, Thompson D, Shapiro RJ, Warnock GL, Andersen DK, Elahi D, Meneilly GS 2006 Effect of glucagon-like peptide-1 (7-37) on β-cell function after islet transplantation in type 1 diabetes. Diab Res Clin Prac 74:189-193
10. Robertson RP 2004 Consequences on β-cell function and reserve after long-term pancreas transplantation. Diabetes 53:633-644
11. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP 1998 Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 47:324-330
12. Roder ME, Porte D, Schwartz RS, Kahn SE 1998 Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608
13. Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D, Robertson RP 1996 Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans. J Clin Invest 97:455-460
14. Meier JJ, Hong-McAtee I, Galasso R, Veldhuis JD, Moran A, Hering BJ, Butler PC 2006 Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes 55:2324-2332
15. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M 1976 Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573
16. Ahren B, Larsson H, Holst JJ 1997 Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:473-478
17. Kjems LL, Holst JJ, Volund A, Madsbad S 2003 The influence of GLP-1 on glucose-stimulated insulin secretion: effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380-386
18. Rachman J, Barrow BA, Levy JC, Turner RC 1997 Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. Diabetologia 40:205-211
19. Ward WK, Halter JB, Beard JC, Porte Jr D 1984 Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 246:E405-E411
20. Rickels MR, Naji A, Teff KL 2007 Acute insulin responses to glucose and arginine as predictors of β-cell secretory capacity in human islet transplantation. Transplantation 84:1357-1360
21. Tillil H, Frank BH, Pekar AH, Broelsch C, Rubenstein AH, Polonsky KS 1990 Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology 127:2418-2422
22. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH 1975 Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278-1283
23. Guldstrand M, Ahren B, Adamson U 2003 Improved β-cell function after standardized weight reduction in severely obese subjects. Am J Physiol 284:E557-E565
24. Desai NM, Goss JA, Deng SP, Wolf BA, Markmann E, Palanjian M, Shock AP, Feliciano S, Brunicardi FC, Barker CF, Naji A, Markmann JF 2003 Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 76:1623-1625
25. Leahy JL, Bonnerweir S, Weir GC 1984 Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33:667-673
26. Guenifi A, Ahren B, bdel-Halim SM 2001 Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro. Pancreas 22:58-64
27. Hostens K, Ling ZD, Van Schravendijk C, Pipeleers D 1999 Prolonged exposure of human β-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab 84:1386-1390
28. Alarcon C, Leahy JL, Schuppin GT, Rhodes CJ 1995 Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest 95:1032-1039
29. McDonald CG, Ryan EA, Paty BW, Senior PA, Marshall SM, Lakey JRT, Shapiro AMJ 2004 Cross-sectional and prospective association between proinsulin secretion and graft function after clinical islet transplantation. Transplantation 78:934-937
30. Nauck MA, Siegel EG, Creutzfeldt W 1991 Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas 6:645-652
31. Al Ghofaili K, Fung M, Ao ZL, Meloche M, Shapiro RJ, Warnock GL, Elahi D, Meneilly GS, Thompson DM 2007 Effect of exenatide on β cell function after islet transplantation in type 1 diabetes. Transplantation 83:24-28
32. Froud T, Faradji RN, Pileggi A, Messinger S, Baidal DA, Ponte GM, Cure PE, Monroy K, Mendez A, Selvaggi G, Ricordi C, Alejandro R 2008 The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation 86:36-45
33. Gangemi A, Salehi P, Hatipoglu B, Martellotto J, Barbaro B, Kuechle JB, Qi M, Wang Y, Pallan P, Owens C, Bui J, West D, Kaplan B, Benedetti E, Oberholzer J 2008 Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant 8:1-12